Viz.ai
PrivateLast Round
Debt
Mar 22, 2023
Est. Valuation
$1.2B
Total Funding Raised
$289.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Viz.ai operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Debt round in March 2023.
Viz.ai is a healthtech company that offers an AI-powered intelligent care coordination platform designed to accelerate disease detection and improve clinical workflows.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics, Vertical SaaS, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Revenue Share, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Viz.ai Comparables
Compare Viz.ai with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aidoc | 93% | |
| RapidAI | 92% | |
| Nicolab | 81% |
For institutional investors. Book with your work email.
Viz.ai Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Mar 22, 2023 | ||||
| Series D | Apr 7, 2022 | ||||
| Series C | Mar 17, 2021 | ||||
| Series B | Oct 23, 2019 | ||||
| Series A | Jul 18, 2018 | ||||
Seed | May 24, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Viz.ai Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Greenoaks Capital Partners | Series C, Series B |
| Threshold Ventures | Series D, Series C, Series B |
| GV | Series D, Series A, Series B |
| Innovation Endeavors | Series C, Seed |
| Tribe Capital | Series D |
| CIBC Innovation Banking | Debt |
| Scale Venture Partners | Series D, Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Organization grew to approximately 150 employees.
- Apr 23, 2026
Collaborating with Johnson & Johnson to expand Subdural Hemorrhage software access.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 20, 2026
Viz.ai, Inc. partners with Novartis to develop AI-powered oncology workflows for patients with breast and prostate cancers in Jun '25.
For institutional investors. Book with your work email.
Viz.ai Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Viz.ai's valuation, stock price, and market status.
Is Viz.ai a public or private company?
Viz.ai is a private company.
What is the current stock price of Viz.ai?
Viz.ai is a private company, so its shares have no public market price. Caplight tracks Viz.ai's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Viz.ai worth (valuation)?
Viz.ai's valuation is estimated at $1.2B based on funding round data.
Can I buy Viz.ai stock?
Viz.ai shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Viz.ai's last funding round?
Viz.ai's most recent funding round was Debt on March 22, 2023.
Who are the main investors in Viz.ai?
Key investors in Viz.ai include Greenoaks Capital Partners, Innovation Endeavors, CIBC Innovation Banking, Scale Venture Partners, Tiger Global Management.
Will Viz.ai IPO soon?
No public IPO plans have been announced for Viz.ai.
How can I track Viz.ai secondary market activity?
Caplight tracks bids, offers, and trades in Viz.ai's shares on secondary markets.